Advertisement Lilly to build new innovation center in Cambridge, US - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Lilly to build new innovation center in Cambridge, US

Eli Lilly and Company is planning to build a new drug delivery and device innovation center in Cambridge, Massachusetts.

Located in Kendall Square, the new Lilly Cambridge Innovation Center will allow leading life science experts and organizations to explore how emerging technologies and connectivity can advance drug delivery and device innovation to improve patient health.

Construction of the new center will begin immediately and is expected to be ready for occupancy by the end of this year.

The company intends to hire about 30 scientists and engineers over the next two years to fulfill the center’s work

When fully operational, the new center will increase the company’s delivery and device research and development space by nearly 50%, while increasing its staff by 25%.

Lilly chairman, president and CEO John Lechleiter said: "The company is locating a portion of its delivery and device organization in Cambridge – one of the nation’s leading regions for research and development of medical delivery technologies – to take advantage of the area’s rich engineering talent base and life sciences ecosystem.

"The Lilly Cambridge Innovation Center complements a deliberate push by the company to be an industry leader in providing convenient, reliable drug delivery and device innovation."

The center will also serve as a portal for external partnerships and collaboration activities with the company’s existing research facilities in San Diego, New York City and Indianapolis.

Lilly Research Laboratories president and executive vice-president of science and technology Jan Lundberg said: "New drug delivery and device innovation is critically important to Lilly’s growing portfolio of potential medicines, particularly in our focus areas of diabetes, neurodegeneration, immunology and pain."